Your browser is no longer supported. Please, upgrade your browser.
Settings
FLKS Flex Pharma, Inc. daily Stock Chart
FLKS [NASD]
Flex Pharma, Inc.
Index- P/E- EPS (ttm)-1.97 Insider Own25.11% Shs Outstand17.66M Perf Week-10.77%
Market Cap20.49M Forward P/E- EPS next Y-1.56 Insider Trans0.00% Shs Float13.50M Perf Month-70.10%
Income-34.40M PEG- EPS next Q-0.45 Inst Own45.70% Short Float1.25% Perf Quarter-82.69%
Sales1.20M P/S17.07 EPS this Y18.00% Inst Trans-2.38% Short Ratio0.52 Perf Half Y-63.29%
Book/sh1.22 P/B0.95 EPS next Y7.70% ROA-90.60% Target Price17.00 Perf Year-73.93%
Cash/sh1.35 P/C0.86 EPS next 5Y- ROE-104.50% 52W Range1.04 - 8.98 Perf YTD-66.76%
Dividend- P/FCF- EPS past 5Y- ROI-119.30% 52W High-87.08% Beta2.83
Dividend %- Quick Ratio6.10 Sales past 5Y- Gross Margin57.80% 52W Low11.54% ATR0.35
Employees20 Current Ratio6.20 Sales Q/Q0.00% Oper. Margin- RSI (14)20.97 Volatility10.64% 12.49%
OptionableYes Debt/Eq0.00 EPS Q/Q6.20% Profit Margin- Rel Volume0.77 Prev Close1.12
ShortableYes LT Debt/Eq0.00 EarningsMay 02 BMO Payout- Avg Volume322.50K Price1.16
Recom1.80 SMA20-61.03% SMA50-70.46% SMA200-71.24% Volume248,475 Change3.57%
Jun-13-18Downgrade Ladenburg Thalmann Buy → Neutral
Jan-25-18Initiated Ladenburg Thalmann Buy $12
Jan-03-18Resumed ROTH Capital Buy $12
Oct-14-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-14-15Initiated H.C. Wainwright Buy $40
Feb-23-15Initiated ROTH Capital Buy $27
Jun-22-18 08:05PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Flex Pharma, Inc. (FLKS) and Encourages Investors to Contact the Firm GlobeNewswire
03:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Flex Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 20, 2018 FLKS GlobeNewswire
01:50PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:03AM  FLEX PHARMA SHAREHOLDER ALERT: Securities Fraud Class Action Filed Against Flex Pharma, Inc. (FLKS); Block & Leviton Encourages Shareholders to Contact the Firm PR Newswire
Jun-20-18 03:14PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Flex Pharma, Inc. Business Wire -5.00%
02:55PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Flex Pharma, Inc. To Contact The Firm GlobeNewswire
02:45PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jun-19-18 05:07PM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire -6.25%
02:50PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Flex Pharma, Inc. (FLKS) and Lead Plaintiff Deadline: August 20, 2018 PR Newswire
02:48PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Flex Pharma, Inc. FLKS Business Wire
01:40PM  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Flex Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline FLKS GlobeNewswire
Jun-14-18 05:55PM  Flex Pharma Down on Workforce Reduction, Ends Phase II Study Zacks +29.81%
03:14PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Flex Pharma, Inc. Business Wire
08:10AM  Todays Research Reports on Stocks to Watch: Flex Pharma and Galectin Therapeutics ACCESSWIRE
Jun-13-18 03:04PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flex Pharma, Inc. - FLKS PR Newswire -75.12%
12:54PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Flex Pharma, Inc. (FLKS) PR Newswire
11:07AM  Bostons Flex Pharma slashes headcount, eyes sale after ALS drug fails American City Business Journals
07:37AM  Flex Pharma to scrap two mid-stage neuromuscular disease trials Reuters
07:22AM  Flex Pharma to cut more than half its workforce, end a phase 2 trial MarketWatch
07:11AM  Flex Pharma to cut 60 percent of workforce Reuters
07:00AM  Flex Pharma Announces Corporate Update Business Wire
May-02-18 06:13PM  Edited Transcript of FLKS earnings conference call or presentation 2-May-18 1:00pm GMT Thomson Reuters StreetEvents -5.35%
07:39AM  Flex Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Flex Pharma Reports First Quarter 2018 Financial Results Business Wire
May-01-18 06:58AM  Does Flex Pharma Incs (NASDAQ:FLKS) Latest Financial Perfomance Look Strong? Simply Wall St.
Apr-25-18 03:19PM  Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018 Business Wire
Mar-26-18 07:00AM  Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis Business Wire +5.22%
Mar-16-18 08:20AM  Todays Research Reports on Stocks to Watch: Flex Pharma, Inc. and Alexion Pharmaceuticals ACCESSWIRE
Mar-13-18 07:30AM  Wired News AmpliPhi Biosciences Presents Pre-Clinical Data Validating AB-PA01s Efficacy in Reducing Biofilm in Pseudomonas Aeruginosa Infections ACCESSWIRE +7.42%
Mar-07-18 06:35PM  Edited Transcript of FLKS earnings conference call or presentation 7-Mar-18 2:00pm GMT Thomson Reuters StreetEvents +13.90%
07:55AM  Should You Buy Flex Pharma Inc (NASDAQ:FLKS) Now? Simply Wall St.
07:15AM  Flex Pharma, Inc. to Host Earnings Call ACCESSWIRE
07:05AM  Flex Pharma reports 4Q loss Associated Press
07:00AM  Flex Pharma Reports Year End 2017 Financial Results Business Wire
Feb-28-18 04:00PM  Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018 Business Wire
Feb-08-18 06:13AM  New Study Shows HOTSHOT Provides Relief From Muscle Soreness For Athletes Of All Types PR Newswire
Feb-06-18 12:00PM  Flex Pharma Presenting at BIO CEO on February 13, 2018 Business Wire +5.48%
Jan-05-18 07:13AM  [$$] Primecap: Two Stocks It's Buying, One It's Selling Barrons.com +7.22%
Jan-03-18 10:58AM  Breaking Down Flex Pharma Incs (NASDAQ:FLKS) Ownership Structure Simply Wall St.
Dec-26-17 02:35PM  What Is Flex Pharma Incs (NASDAQ:FLKS) Financial Position? Simply Wall St.
11:32AM  ETFs with exposure to Flex Pharma, Inc. : December 26, 2017 Capital Cube
Dec-22-17 09:28AM  Flex Pharma, Inc. :FLKS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017 Capital Cube
Dec-05-17 08:20PM  Should You Be Content With Flex Pharma Incs (FLKS) 18.4% Earnings Growth? Simply Wall St. -12.06%
Nov-28-17 08:00AM  Enrollment Completed in Flex Pharmas Phase 2 Exploratory Spasticity Study in MS Business Wire
Nov-27-17 12:00PM  Arnold & Havas Media, Gear Communications Awarded HOTSHOT® Creative, Media & PR Duties PR Newswire
Nov-06-17 06:50PM  Edited Transcript of FLKS earnings conference call or presentation 6-Nov-17 1:45pm GMT Thomson Reuters StreetEvents
08:09AM  Flex Pharma reports 3Q loss Associated Press
08:00AM  Flex Pharma Reports Third Quarter 2017 Financial Results Business Wire
07:00AM  Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS Business Wire
06:20AM  Flex Pharma, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 08:30AM  Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017 Business Wire +9.21%
Oct-31-17 09:15AM  Should You Buy Flex Pharma Inc (FLKS) Now? Simply Wall St.
08:30AM  Flex Pharma Names Dr. Roger Tung to Its Board of Directors Business Wire
Oct-16-17 08:30AM  Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US Business Wire
Sep-06-17 04:40PM  Flex Pharma Presenting at Upcoming Investor Conferences in September 2017 Business Wire -13.81%
Sep-01-17 07:50PM  ETFs with exposure to Flex Pharma, Inc. : September 1, 2017 Capital Cube
Aug-24-17 11:12AM  Flex Pharma, Inc. :FLKS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-03-17 07:33AM  Edited Transcript of FLKS earnings conference call or presentation 2-Aug-17 12:45pm GMT Thomson Reuters StreetEvents
Aug-02-17 10:47PM  Flex Pharma reports 2Q loss Associated Press -9.71%
07:30AM  Flex Pharma Reports Second Quarter 2017 Financial Results Business Wire
06:50AM  Investor Network: Flex Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 07:30AM  Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US Business Wire
Jul-31-17 07:30AM  Flex Pharma Names William McVicar President and Chief Executive Officer Business Wire
Jul-27-17 07:00AM  Corporate News Blog - FDA Grants Fast Track Designation to Flex Pharmas FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS ACCESSWIRE
Jul-26-17 08:00AM  Today's Research Reports on Stocks to Watch: Neuralstem and Flex Pharma Accesswire -5.77%
08:00AM  Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017 Business Wire
Jul-25-17 07:30AM  FDA Grants Fast Track Designation to Flex Pharmas FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS Business Wire +11.03%
Jun-05-17 04:10PM  Flex Pharma Announces Executive Leadership Transition Business Wire
Jun-02-17 08:00AM  Flex Pharmas Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium Business Wire
May-30-17 09:23AM  Flex Pharma Presenting at Upcoming Investor Conferences in June 2017 Business Wire
May-04-17 11:58AM  Edited Transcript of FLKS earnings conference call or presentation 3-May-17 12:45pm GMT Thomson Reuters StreetEvents +5.81%
May-03-17 07:26AM  Flex Pharma reports 1Q loss Associated Press
07:15AM  Flex Pharma Reports First Quarter 2017 Financial Results Business Wire
Apr-26-17 08:00AM  FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND Business Wire +15.96%
Apr-19-17 08:00AM  Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting Business Wire
Apr-05-17 08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development Business Wire
08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Mar-23-17 07:45AM  Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps PR Newswire
Mar-14-17 01:04PM  FLEX PHARMA, INC. Financials
Mar-09-17 09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT Thomson Reuters StreetEvents
09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT
Mar-08-17 08:30AM  Flex Pharma Inc Earnings Call scheduled for 8:30 am ET today -16.67%
07:52AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:16AM  Flex Pharma reports 4Q loss Associated Press
07:16AM  Flex Pharma reports 4Q loss
07:07AM  Q4 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Year End 2016 Financial Results Business Wire
Mar-01-17 03:36PM  Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017 Business Wire
Feb-23-17 08:44AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-15-17 02:52PM  Champion Triathlete Finds Solution For Struggle With Muscle Cramps PR Newswire
Feb-07-17 01:31PM  Flex Pharma to Present at the BIO CEO & Investor Conference Business Wire
Jan-24-17 07:30AM  Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases Business Wire
Dec-20-16 12:53PM  Champion Pro Football Fullback Goes On The Offense Against Game-Changing Cramps PR Newswire
Dec-15-16 01:04PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial
Dec-12-16 06:01PM  Do Hedge Funds Love Vishay Precision Group Inc (VPG)? at Insider Monkey -6.20%
Nov-21-16 06:07PM  Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference Business Wire
Nov-15-16 08:03AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-09-16 12:00PM  Flex Pharma to Present at the Jefferies 2016 Healthcare Conference Business Wire
Nov-03-16 07:56AM  Edited Transcript of FLKS earnings conference call or presentation 2-Nov-16 12:45pm GMT -5.27%
Nov-02-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today
Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which is in exploratory Phase 2 clinical trial in Australia for the treatment of patients with multiple sclerosis; and two Phase 2 clinical trials in the United States for the treatment of patients with motor neuron disease in amyotrophic lateral sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT product online through its e-commerce Website, as well as through specialty retailers. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.